Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 21.71% vs -17.37% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 25.60% vs -22.01% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 33.65% vs -24.61% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 21.43% vs -27.59% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Glaxosmi. Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 21.71% vs -17.37% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -3.05% vs 5.62% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 25.60% vs -22.01% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1.98% vs 16.09% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 33.65% vs -24.61% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 4.36% vs 11.13% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 21.43% vs -27.59% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 88.89% vs -37.21% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






